Cold chain and market access
- The Medicine Maker argued reliable cold chains are essential for equitable medicine access, beyond mere transport. - Separately, China granted export licences to eight Australian meat facilities, including two abattoirs and six cold-storage centres. - Regulatory permissions and audited cold storage can reshape corridor economics and give compliant firms a first-mover advantage ( ).
A cold chain is not just refrigerated transport; it is the storage, power, monitoring and paperwork that keep sensitive goods saleable or usable. (themedicinemaker.com) In an April 21 article, *The Medicine Maker* said 40 to 60 percent of pharmaceuticals now need temperature-controlled logistics, and advanced cell and gene therapies can require storage from minus 60 to minus 150 degrees Celsius. It said even a 1 to 2 degree Celsius deviation can degrade vaccines, insulin and biologics. (themedicinemaker.com) The same article said about 12 percent of pharmaceutical shipments still experience temperature excursions, and cited World Health Organization estimates that up to 50 percent of vaccines are compromised each year by temperature-control and logistics failures. The World Health Organization says immunization programs depend on end-to-end systems that keep vaccines within range from manufacturer to clinic. (themedicinemaker.com; who.int) That same logic showed up in food trade on April 17, when China’s customs authority approved eight Australian beef facilities for export access. ABC reported the list included six distribution centres, described as cold stores, and two abattoirs. (abc.net.au) ABC said the two newly approved abattoirs included Thomas Foods International near Murray Bridge in South Australia and Nolan Meats in Queensland. Beef Central separately reported Hardwicks Meat Works also appeared on the Chinese list, but said it could not confirm whether that entry was the processing plant itself or an associated cold-storage site. (abc.net.au; beefcentral.com) China also approved 13 already listed Australian abattoirs to export additional product, and meat analyst Simon Quilty told ABC those licences were being upgraded from frozen to chilled beef. Agriculture Minister Julie Collins said the added access highlighted the “high quality and safe beef” Australia exports. (abc.net.au) The timing was awkward because China imposed a 205,000-tonne safeguard quota on Australian beef for 2026, after which a 55 percent tariff applies for the rest of the year. ABC said Australia was on track to hit that quota by mid-June, while Beef Central said Australia had already filled 51.3 percent of it by the end of March. (abc.net.au; beefcentral.com) That is why the approvals look less like a volume story than a corridor story. Expana analyst Junie Lin told Beef Central the change was “less about moving more beef, and more about moving higher-value product,” because chilled and premium cuts can earn more within the same cap. (beefcentral.com) In both medicines and meat, the bottleneck sits in the middle of the route, not at the factory gate. Firms that already have audited cold rooms, compliant monitoring and the right export permissions can ship first, while rivals wait for inspections, approvals or storage upgrades. (themedicinemaker.com; abc.net.au; beefcentral.com) The practical lesson is simple: market access often turns on whether a product can stay in spec from origin to arrival. When regulators approve the cold chain as well as the producer, trade lanes and treatment access can change overnight. (themedicinemaker.com; abc.net.au)
